U.S. and Low- and Middle-Income Country (LMIC) HIV-Associated Malignancy Research Centers (U54 Clinical Trials Optional)

archived

The purpose of this Funding Opportunity Announcement (FOA) is to support research on HIV-associated cancers in low- and middle-income countries (LMICs) through collaborative networks between investigators in United States (U.S.) and investigators in LMICs. The FOA solicits applications for Specialized Center Cooperative Agreements (U54) for research on HIV-associated cancers from research institutions in the U.S. and LMICs. Each application is required to propose between one to three research projects that address questions in one theme that are relevant to the LMICs and the U.S. The proposed projects may range, as appropriate, from basic research to translational efforts as well as population and implementation studies; mechanistic clinical studies that meet NIH's definition of a clinical trial will be allowed. In addition, the proposed networks must include two mandatory cores; an Administrative Core and a Developmental Core. Additional cores such as Shared Resource cores may be included as appropriate for the needs of the projects.

High